VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0920861
Sex: F
Age: 39
State: TX

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: n/a

Allergies: n/a

Symptoms: Client experienced nausea and slight dizziness while walking to be seen by EMT 4 minutes after vaccine was administered. Client's symptoms stopped while with EMT. EMT checked cleared client with no issues. Client confirmed she was okay to go home. No medications were administered.

Other Meds: n/a

Current Illness: No illnesses mentioned

ID: 0920862
Sex: F
Age: 26
State: SC

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: none

Allergies: caffeine

Symptoms: headache, low grade fever,runny nose, loss taste and smell, feels flushed

Other Meds: Vitamins,Claritin, Singular

Current Illness: none

ID: 0920863
Sex: F
Age: 53
State: CA

Vax Date: 01/03/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: unknown

Symptoms: Arm has a huge redness around injection site. "Not feeling well." "hot/cold sweats"

Other Meds: unknown

Current Illness: unknown; "recently recovered from COVID", do not have exact timeframe

ID: 0920864
Sex: F
Age: 43
State: VA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: Quinolones

Symptoms: Moderna COVID-19 Vaccine EUA Headache, chills, body aches, fever, nausea

Other Meds: none

Current Illness: none

ID: 0920865
Sex: M
Age: 54
State: NY

Vax Date: 12/23/2020
Onset Date: 01/01/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: Rapid Test and PCR test positive for Covid Sat Jan 2.

Allergies: none

Symptoms: On Jan 1 came down with fever, chills, aches and pain.

Other Meds: none

Current Illness: none

ID: 0920866
Sex: F
Age: 27
State:

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Got second shot in the morning: Last night 11:00pm started having fever 101, chill, bad headache. Took Tylenol. Today has a little headache, no fever, chills are better. Don't feel well enough to go to work.

Other Meds:

Current Illness:

ID: 0920867
Sex: F
Age: 53
State: TX

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: no

Symptoms: fever, body aches, chills, headaches all for 48 hours starting on 12/31/2020

Other Meds: Thrive energy pill, Xanax .5 mg, fish oil 2000mg, Co Q 10 100mg, Linzess 146mg,

Current Illness: none

ID: 0920868
Sex: M
Age: 69
State: NY

Vax Date: 01/03/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: None

Allergies: Mussels

Symptoms: Tenderness around injection site, slight fatigue, slight chills, slight fever. No treatment other than sleep and rest. Symptoms disappear by Wednesday, 1/5/2021, a.m.

Other Meds: Vitamin B, C, D, Metformin, Aspirin, Losartan, Simvastatin

Current Illness: None

ID: 0920869
Sex: F
Age: 59
State: NY

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: placed on stretcher, po fluids given

Allergies: Cipro

Symptoms: mild flushing, elevated temp 99.2, nausea

Other Meds:

Current Illness:

ID: 0920870
Sex: F
Age: 24
State: ME

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: Patient with history of anaphylaxis x2 - trigger unknown. Last epi-pen use 2016

Symptoms: At 2:08pm patient received dose #1 of Moderna COVID-19 vaccine. She began having lip tingling, lightheadedness and chest pounding at 2:10pm. On exam her BP was 126/82, HR 113, 95% O2 sat on RA. Patient was administered 50 mg of oral Benadryl at 2:17pm. She developed a rash on her chest and neck ? not hives. Lip tingling and chest pounding improved. Rescue arrived and upon discharge from the clinic to EMS her HR was 100, 99% O2 sat on RA. PMH significant for chronic urticaria and angioedema with 4 lifetime episodes of severe allergic reactions, but never to a vaccine. Had had epi administered x 2, last in 2016.

Other Meds:

Current Illness:

ID: 0920871
Sex: F
Age: 40
State: AL

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Visited walk in doctor clinic for sinus pressure and pain and was given a steroid shot, an oral steroid and antibiotics

Allergies: Ceclor and eggs

Symptoms: Sinus pressure that could be felt in my teeth and headache began about 2 hours after vaccine. It has been almost a week and these sensations remain.

Other Meds: None

Current Illness: Sinusitis and bronchitis one month prior

ID: 0920872
Sex: F
Age: 39
State: NJ

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever, chills, joint pain, headache, nausea, fatigue, bodyaches

Other Meds: Wellbutrin, Buspar

Current Illness:

ID: 0920873
Sex: F
Age: 44
State:

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: BP 116/70 HR 74 O2 sat 100%

Allergies:

Symptoms: Pt developed dizzyness - increased upon standing-postural changes . Drank water and observed for 40 minutes w/o improvementVS

Other Meds:

Current Illness:

ID: 0920874
Sex: M
Age: 30
State: AZ

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: N/A

Allergies: N/A

Symptoms: 12/18 VACCINATION 12/19 WOKE UP, HA, FATIGUE, MUSCLE ACHES. 12/20; HA WORSE, SYMPTOMS WORSE 12/21 FELT BETTER 12/22 VERTIGO, FACE IS RED. URGENT CARE. PRESCRIBED NAUSEA MEDS.

Other Meds: MULTIVITAMIN; FISH OIL

Current Illness: N/A

ID: 0920875
Sex: F
Age: 31
State: TX

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: N/A

Allergies: None

Symptoms: Significant soreness in the arm where I received the injection, as well as a swollen lymph node in the underarm of the same arm. In addition, muscle aches, fatigue and chills. No fever recorded so far.

Other Meds: Phentermine 37.5 mg (for weight loss) , Aimovig 70 mg injection (for migraines)

Current Illness: I tested positive for COVID-19 on 12/1/2020.

ID: 0920876
Sex: F
Age: 43
State: TN

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizziness, nausea, light headedness, palpitations

Other Meds:

Current Illness:

ID: 0920877
Sex: F
Age: 57
State: MI

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: All tests done in emergency room 12/30/2020 (EKGs and blood work)

Allergies: erythromycin, vancomycin (both rash only)

Symptoms: Shortly after vaccination developed dizziness and nausea. Within 30 minutes had low blood pressure and pulse. Taken to ER. Also developed vomiting. Treated with epinephrine. Initially improved, then after 40 minutes heart rate dropped to low 40's and developed chest pain. Treated with 4 mg solumedrol, benadryl and more IV fluids. Slow recovery and observed over 5 hours. Went home.

Other Meds: propranolol, topamax

Current Illness: None

ID: 0920878
Sex: F
Age: 35
State: MA

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: Cats, seasonal allergies

Symptoms: Sore arm Pregnant at time of administration

Other Meds: Prenatal, aspirin

Current Illness:

ID: 0920879
Sex: F
Age: 36
State: WI

Vax Date: 12/23/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital: Y

Lab Data: Labs drawn, abdominal ultrasound and ct scan performed. Stones found in appendix

Allergies: None

Symptoms: Abdominal pain that proceeded to get worse into the next day. Connected with PCP, had labs drawn and ultrasound ordered. Ended up going to ER. Determined to have Appendicitis, needed and had appendectomy on 12/29/2020.

Other Meds: None

Current Illness: None

ID: 0920880
Sex: F
Age: 15
State: WA

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient vaccinated outside of age range for vaccine

Other Meds:

Current Illness:

ID: 0920881
Sex: F
Age: 32
State: WA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: None

Allergies: Allergic to Demerol

Symptoms: Around 10 am (2hrs post vaccination) I noticed some hives on my hands and dizziness. I also developed a mouth sore that later went away around 5pm. I drank 1.5 L of water and put some topical Benadryl cream on the hives, these symptoms resolved. At 8pm I began to get a temperature (temp max 101.2 around 11:17pm), a very sore swollen arm, massive headache, and myalgia/arthralgia in knees bilaterally. On 1/5 temperature has subsided to low grade (99.2F) but I still don?t feel well and have no sense of smell with a runny nose.

Other Meds: -woman?s multivitamin -vitamin d 5000 IU

Current Illness: -contracted COVID 19 on 12/16...had been cleared by my PA and hospital to receive vaccine despite this

ID: 0920882
Sex: F
Age: 60
State: MN

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: n/a

Allergies: Sulfa drugs Erythromycin Vancomycin Chocolate Fish Dust Weeds

Symptoms: Immediately after injection into patient's left deltoid, site swelling and felt firm. Some bruising noted. Ice applied and patient monitored for over 30 minutes. Patient did complain of scratchy throat while being monitored, but refused Benadryl at this time. Patient will notify her physician of this reaction to the vaccine.

Other Meds: Losartin for BP Omeprazole GI

Current Illness: None

ID: 0920883
Sex: F
Age: 54
State: GA

Vax Date: 12/24/2020
Onset Date: 01/01/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: Blood Lab test 01/05/2021 in Doctors Office , Physical Exam 01/05/2021

Allergies:

Symptoms: Fatigue four days after vaccine. Shingles diagnosed one week after vaccine.

Other Meds: Olemesartan, Cetrizine, VitaminB-12, Vitamin D3, Zinc , Iron

Current Illness:

ID: 0920884
Sex: F
Age: 45
State: KY

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: NKA

Symptoms: Elevated heart rate, shortness of breath, fever (101.3), body aches, nausea, fatigue, impaired sleep - lasted 2 days

Other Meds: Vitamin D, Biotin, Multi Vitamin, Airbourne supplement

Current Illness: COVID-19 diagnosis 12/7/21, able to return to work on 12/28, during illness fever (102.5) body aches, chills, decreased smell/taste, nausea, low appetite, elevated heart rate, short of breath, fatigue, poor sleep Went ED 12/16 with severe shortness of breath, heart rate up to 140's - treated with antibody regimen infusion.

ID: 0920885
Sex: F
Age: 23
State: GA

Vax Date: 12/19/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: COVID 19 PCR negative 12/23/2021

Allergies: seasonal

Symptoms: Fever 101.0 F, dry cough,nasal congestion , recovered within 72 hours

Other Meds: Ibuprofen

Current Illness: none

ID: 0920886
Sex: F
Age: 58
State: KY

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: None

Allergies: Lortab

Symptoms: Rigorous chills x 3 hours, temperature up to 104.0 by mouth, increased arm tenderness (unable to lay on that side), malaise, body aches. All symptoms lasted approximately 14 hours and then resolved except for the arm soreness which resolved in 3 days. Treated fever with acetaminophen and Ibuprophen.

Other Meds: Rosuvastatin, multi vitamin, phentermine

Current Illness: none

ID: 0920948
Sex: U
Age:
State: LA

Vax Date: 12/14/2020
Onset Date: 12/14/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: temperature excursion; Dose/Frequency: 0.5 ml of ROTATEQ; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent condition, pertinent medical history and drug allergies and reactions were not reported. On 14-DEC-2020, the patient was vaccinated with the temperate excursion vaccines of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (strength was not provided; lot# was S040483 and expiration date was 19-JUN-2021) 0.5 ml orally and haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength and route were not provided; lot# was T001206 and expiration date was 03-JUN-2022) 0.5 ml for prophylaxis. This is one of three cases from the same reporter.; Sender's Comments: US-009507513-2012USA007474: US-009507513-2012USA007679:

Other Meds:

Current Illness:

ID: 0920949
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: migraine headache; Information has been received from a consumer referring to her daughter, a currently 21 years old female patient. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On an unknown date in 2010 (reported as when the patient was 11 years old), the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (strength, dose, route of administration, lot number and expiration date were not provided) for prophylaxis. On an unknown date, the patient experienced migraine headaches. The reported wanted to know why so much aluminum was put in the vaccine. The reporter stated her father was a judge and they were going to sue the balls off. The outcome of the event of migraine headaches was unknown. The causality between migraine headaches and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was unknown.

Other Meds:

Current Illness:

ID: 0920950
Sex: U
Age: 13
State: PA

Vax Date: 10/10/2019
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: PROQUAD was administered to a 14 year old patient.; This spontaneous report was received from an educator referring to a 14-year-old patient. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 31-AUG-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) lot # S035111, expiration date 03-MAY-2021, at a dose of 2.5 milliliter for prophylaxis. The reporter stated they are aware of the prescribing information that measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) should be administered between 12 months and 12 years. The reporter stated the patient had their initial dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) on 10-OCT-2019 and that the dose on 31-AUG-2020 was the second in the series. The reporter was requesting information on how to proceed, if the patient's dose was valid.

Other Meds:

Current Illness:

ID: 0920951
Sex: U
Age: 64
State: CA

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: administered IM instead of SC; This spontaneous report was received from a physician referring to a 64 year old patient of unknown gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided. On 21-DEC-2020, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) lot # S039311, expiration date 04-DEC-2021 for prophylaxis (strength, dose and frequency were not reported). The vaccine was administered via intramuscular rather than subcutaneous. No further information provided.

Other Meds:

Current Illness:

ID: 0920952
Sex: U
Age:
State: AR

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nurse gave Varivax that expired 08/22/2020; This spontaneous report was received from a customer via email and refers to an adult patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) that expired on 22-AUG-2020, (dose, anatomical location, route of administration and lot# were not reported) for prophylaxis.

Other Meds:

Current Illness: Prophylaxis

ID: 0920953
Sex: U
Age:
State: CA

Vax Date: 09/08/2020
Onset Date: 09/08/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AE/PQCs reported; administration of improperly stored PROQUAD; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-SEP-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) lot # T015598, expiration date: 02-NOV-2021 for prophylaxis (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.5 degrees Fahrenheit (F) for 1 hour 54 minutes and the previous excursion of 6F to 14F (12.3F) for 23 hours. Digital data logger was involved.

Other Meds:

Current Illness:

ID: 0920954
Sex: U
Age:
State: CA

Vax Date: 08/28/2020
Onset Date: 08/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AE; improperly stored PROQUAD; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 28-AUG-2020, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) 1 dosage form, lot number T015598, expiration date 02-NOV-2021 (route of administration was not provided) for prophylaxis. No additional adverse events were reported. The vaccine had a temperature excursion of 20.5 degrees Farhrenheit (?F) for 1 hour and 54 minutes. The previous temperature excursion was between 6?F and 14?F, with an average of 12.3?F for 23 hours. The call was due to digital data logger.

Other Meds:

Current Illness:

ID: 0920955
Sex: M
Age:
State:

Vax Date: 10/20/2017
Onset Date: 11/20/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tired; This case was reported by a consumer and described the occurrence of tiredness in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on unknown date). On 20th October 2017, the patient received the 2nd dose of Shingrix. On 20th November 2020, 1127 days after receiving Shingrix, the patient experienced tiredness. On 20th November 2020, the outcome of the tiredness was recovered/resolved. The reporter considered the tiredness to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of shingrix and experienced tiredness. This case has been linked with US2020AMR233686, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2020AMR233686:same reporter

Other Meds:

Current Illness:

ID: 0920956
Sex: M
Age: 66
State: PA

Vax Date: 10/28/2020
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: low grade fever; hard lump at injection site; redness / at injection site; sore at injection site; This case was reported by a consumer via call center representative and described the occurrence of low grade fever in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 28th October 2020, the patient received the 1st dose of Shingrix. In October 2020, less than a week after receiving Shingrix, the patient experienced low grade fever, injection site lump, injection site erythema and injection site pain. On an unknown date, the outcome of the low grade fever, injection site lump and injection site erythema were recovered/resolved and the outcome of the injection site pain was unknown. It was unknown if the reporter considered the low grade fever, injection site lump, injection site erythema and injection site pain to be related to Shingrix. Additional details were reported as follows: The patient received 2st dose of Shingrix and experienced low grade fever, hard lump at injection site, redness and sore at injection site. The all the symptoms were resolved after 1 week of vaccination. The reporter did not consent to follow up.

Other Meds:

Current Illness:

ID: 0920957
Sex: U
Age:
State:

Vax Date: 12/13/2020
Onset Date: 12/13/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: covid; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: did not feel good for a couple of hours; This is a spontaneous report from a Pfizer-sponsored program received from a non-contactable consumer. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (dipht crm197 protein), via an unspecified route of administration on 13Dec2020 at single dose for immunization. The patient's medical history included COVID-19; relevant concomitant medications were not reported. The patient reported that he/she did not feel good for a couple of hours after vaccine, but it went away. He/she has had COVID but does not know if he/she still has antibodies or not. He/she doesn't want that again. He/she hopes pneumococcal 13-valent conjugate vaccine (dipht crm197 protein) does not hurt him/her because he/she has had COVID. The reported event had resolved at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0920958
Sex: F
Age:
State: CA

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: COVID; Test Result: Negative

Allergies:

Symptoms: felt like she had a stroke; fell down; Pain in leg; itchiness in her head; left leg not functioning normally; This is a spontaneous report from a contactable nurse (reporting for herself). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EH9899), via an unspecified route of administration in the left deltoid on 21Dec2020 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunization. Medical history was none. There were no concomitant medications. There were no prior vaccinations within 4 weeks prior to the first administration of the suspect vaccine. On 21Dec2020, the patient experienced left leg not functioning normally, which was reported with the seriousness criteria of disability. On 21Dec2020, the patient had itchiness in her head. The patient felt like she had a stroke, fell down and pain in leg on 22Dec2020, which were all reported with the seriousness criteria of disability. The patient called the doctor office and spoke with the doctor on call and was told to use diphenhydramine hydrochloride (BENADRYL). No further details provided. The patient was sent home for 10 days and she was sent back to work. The patient underwent lab tests and procedures which included COVID: negative in Dec2020. The outcome of the events was not recovered. The reported assessed the events related to the suspect product, BNT162B2.; Sender's Comments: The reported events leg dragging, leg pain and fall and suspected stroke were possibly related to the use of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to temporal relationship. However, stroke was not diagnosed. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0920959
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: rapid test for COVID; Test Result: Positive

Allergies:

Symptoms: Had a rapid test for COVID, and it was positive; Had a rapid test for COVID, and it was positive; This is a spontaneous report from a contactable pharmacist. A male patient of an unspecified age started to receive BNT162B2 (lot number unknown), via an unspecified route of administration from an unspecified date to an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The pharmacist stated that they have vaccinated all their caregivers, and a physician (patient) who got the vaccine, called and reported to her that he had a rapid test for COVID, and it was positive. She is wondering if there was any data from the clinical trials where people tested positive after having the vaccine. The patient is now freaking out because he does not know if he needs to go to the hospital and get treatment for COVID. He works night shift and may have been exposed to COVID, but now she does not know how to guide him. The outcome of the events was unknown. The following information on the batch number has been requested.; Sender's Comments: The reported positive rapid test for COVID after COVID-19 immunization is considered related to the administration of BNT162B2.

Other Meds:

Current Illness:

ID: 0920960
Sex: F
Age:
State: TX

Vax Date: 12/17/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201222; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive; Test Date: 20201222; Test Name: Rapid Antigen; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: Systemic pruritis (itching) all over body; COVID test type: Nasal Swab and Rapid Antigen and were both positive; COVID test type: Nasal Swab and Rapid Antigen and were both positive; This is a spontaneous report from a contactable nurse (patient). A 26-year-old female patient started to receive BNT162B2 (lot number: EJ1685), intramuscular on 17Dec2020 16:30 at single dose in the left arm for COVID-19 immunization. Medical history included hypothyroidism from an unknown date. The patient was not pregnant at the time of vaccination. Concomitant medication included levothyroxine sodium (SYNTHROID) and spironolactone. The patient previously took cefprozil (CEFZIL) and tapazole and both experienced allergies. The patient experienced systemic pruritis (itching) all over body on 22Dec2020 10:00. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient has been tested for COVID-19. On 22Dec2020, the patient took COVID test type: Nasal Swab and Rapid Antigen and were both positive. No treatment received for the event "Systemic pruritis (itching) all over body". The outcome of the event "Systemic pruritis (itching) all over body" was not recovered. The outcome of the other events was unknown.; Sender's Comments: BNT162b2 provides protection against COVID-19 after 7 days from the second dose. This case does not match this codition

Other Meds: SYNTHROID; SPIROLACTONE

Current Illness:

ID: 0920961
Sex: F
Age:
State: CA

Vax Date: 12/19/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201222; Test Name: NAAT-PCR; Test Result: Positive

Allergies:

Symptoms: result back w positive covid; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable nurse reporting for herself. A 39-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 19Dec2020 11:00 (at age 39 years old) as a single dose (Dose 1) in the left arm for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. The patient was not administered any other vaccine in the 4 weeks prior to COVID-19 vaccination. Medical history was none. There were no allergies to medication, food, or other products. The patient's concomitant medications were not reported; however the patient had not received any other medications in the last 2 weeks. The patient experienced a sore throat, voice loss on day 4, loss of smell on day 5, went to test, and the result came back with positive COVID. The events resulted in a Doctor's office visit. The patient was tested post vaccination on 22Dec2020 via NAAT-PCR (nasal swab), with a positive result. The patient had not been diagnosed with COVID-19 prior to vaccination. There was no treatment received for the event(s). The clinical outcome of the event positive COVID was unknown The event was reported as non-serious. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The association between the event drug ineffective (COVID-19 infection) with BNT162b2 can not be fully excluded.

Other Meds:

Current Illness:

ID: 0920962
Sex: F
Age:
State: MA

Vax Date: 12/17/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I had soreness; started with itching, redness and swelling at site of immunization.; started with itching, redness and swelling at site of immunization./5.0 cm area of redness and induration; 5.0 cm area of redness and induration at site; started with itching, redness and swelling at site of immunization.; This is a spontaneous report from a contactable physician (patient herself). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ek5730, expiry date not reported), via an unspecified route of administration on the left arm on 17Dec2020 10:15 at single dose for COVID-19 immunisation. Medical history included food allergy, oral allergy, no anaphylaxis. Concomitant medications were not reported. On 26Dec2020 18:00, the patient started with itching, redness and swelling at site of immunization. Patient also had a 5.0 cm area of redness and induration at site. Patient also had soreness on an unspecified date but no other reaction. No therapeutic measure was taken as a result of the events. Clinical outcome of pain was unknown while for the other events was not recovered. Follow-up attempts are not possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920963
Sex: M
Age:
State:

Vax Date: 12/24/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain on the injection site; chill; nausea; lightheaded; This is a spontaneous report from a contactable physician via a Pfizer colleague. The Pfizer colleague received from a friend a video where the physician (also the patient) was interviewed on 25Dec2020 after getting the Pfizer/BioNtech vaccination and he reported the symptoms described below. An adult male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unkown, expiry date not reported), via an unspecified route of administration on the left arm on 24Dec2020 at a single dose for COVID-19 immunisation. Medical history was unknown. It was unknown if the patient was allergic to medication, food or other products and it was not known if the patient was diagnosed with COVID-19 before vaccination or if the patient had been tested for COVID-10 since the vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. On 24Dec2020, the patient experienced pain on the injection site (was still ongoing on 25Dec2020); also chill, nausea and lightheadedness which all disappeared 30 minutes after the injection. Clinical outcome of pain on the injection site was unknown, while for the other events was recovered on 24Dec2020. The batch/lot number was unknown as it was not available or not provided by the reporter at the time of report completion. Follow-up attempts are not possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920964
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201223; Test Name: Covid 19; Test Result: Positive

Allergies:

Symptoms: tested positive for covid19/diagnosed with Covid; tested positive for covid19/diagnosed with Covid; she had SOB the day of her first vaccination; I am very sick; I feel bad; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first dose of COVID-19 vaccine on Monday, 21Dec2020 and then was diagnosed with COVID-19 on 23Dec2020. Added that she was very sick and wondering if he'll get her second dose or not. The patient feel bad and is due for her second dose on 11Jan2021. The patient also reported that she had shortness of breath (SOB) the day of her first vaccination on 21Dec2020 and then tested positive for COVID-19 later. She posits she may have received the vaccine when she had an active COVID-19 infection. She is wondering if she can still get her second vaccination. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0920965
Sex: F
Age:
State: PA

Vax Date: 12/18/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201226; Test Name: covid_tested_post_vaccination; Test Result: Positive

Allergies:

Symptoms: tested positive for COVID-19; headache; cough; voice being hoarse; Drug ineffective; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect from a Contactable nurse reporting for herself. A 58-years-old female patient received bnt162b2 (BNT162B2; Lot # EK5730) vaccine , via an unspecified route of administration on 18Dec2020 10:30 at single dose for covid-19 immunisation . Medical history included hypertension from an unknown date and blood cholesterol increased. Concomitant medication included losartan (LOSARTAN), hctz (HCTZ), ezetimibe (ZETIA), famotidine (PEPCID). The patient started having a headache and cough on 25Dec2020 and these symptoms worsened on 26Dec2020 in addition to her voice being hoarse. On 26Dec2020 she went to get tested at an urgent center and tested positive for Covid-19. The outcome of the event was not recovered.; Sender's Comments: The association between the event "tested positive for COVID-19, headache, cough, and dysphonia" with BNT162b2 can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: ; HCTZ; ZETIA; PEPCID

Current Illness:

ID: 0920966
Sex: F
Age:
State: NY

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Approximately 15 small pencil point red bumps on arms and legs. Itchy. Not raised. Did not increase in size. Kept appearing within 5 days after the shot.; This is a spontaneous report from a contactable nurse (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot number: EK5730 intramuscular in the left deltoid, from 22Dec2020 15:00 at a, single dose, for COVID-19 immunization. Patient received another Pfizer vaccine on the same date. Medical history included hypertension (HTN), guillain-barre syndrome from 2008. Patient's allergies included penicillin and ASA. Concomitant medication included paroxetine and amlodipine. On 23Dec2020 08:00, approximately 15 small pencil point res bumps on arms and legs. Itchy. Not raised. Did not increase in size. Kept appearing within 5 days after the shot. The outcome of events was recovered. no treatment or hospitalization was required. Follow-up attempts are completed. Information on the batch/lot number has been obtained.

Other Meds: ;

Current Illness:

ID: 0920967
Sex: F
Age:
State: NY

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:101.8 Fahrenheit; Test Name: temperature; Result Unstructured Data: Test Result:102.4 Fahrenheit; Test Name: temperature; Result Unstructured Data: Test Result:101.3 Fahrenheit; Test Name: temperature; Result Unstructured Data: Test Result:100.6 Fahrenheit; Test Name: temperature; Result Unstructured Data: Test Result:99.2 Fahrenheit; Test Date: 20201224; Test Name: temperature; Result Unstructured Data: Test Result:103.8 Fahrenheit; Test Date: 202005; Test Name: COVID-19; Result Unstructured Data: Test Result:Positive; Test Date: 20201223; Test Name: COVID-19; Result Unstructured Data: Test Result:Negetive

Allergies:

Symptoms: I had a temperature of 103.8; nauseated and dizzy; eyes hurting; headache; chills; tired; nauseated and dizzy; pain at the site; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular on 23Dec2020 at 10:30 as single dose for covid-19 immunization. Medical history included covid-19 from May2020. The patient's concomitant medications were not reported. The patient reported that " I had a temperature of 103.8 " on an unspecified date with outcome of unknown; pain at the site on 23Dec2020 with outcome of unknown; tired on 24Dec2020 with outcome of unknown; nauseated and dizzy on 24Dec2020 with outcome of unknown; chills on 24Dec2020 with outcome of unknown; eyes hurting on an unspecified date with outcome of unknown; headache on 24Dec2020 with outcome of unknown. The patient underwent lab tests and procedures which included body temperature: 101.8 Fahrenheit; temperature: 102.4 Fahrenheit; temperature: 101.3 Fahrenheit; temperature: 100.6 Fahrenheit; temperature: 99.2 Fahrenheit; temperature: 103.8 Fahrenheit on 24Dec2020; sars-cov-2 test: positive in May2020, sars-cov-2 test: negative in 23Dec2020. Therapeutic measures were taken as a result of " I had a temperature of 103.8 ". Details were as follows: the nurse received the vaccine on a Wednesday 23Dec2020 at 10:30am. That night at her night shift, she had pain at the site. After midnight, the patient felt tiredness and felt like she had to lay down. At 6:00 she felt nauseated and dizzy. She had a temperature of 103.8. Thursday night, she went home at 7:10 and called her private doctor. The temperature was 101.8 and then it went down. The nurse had been administered the first of 2 dose series of Pfizer BioNTech COVID-19 Vaccine on 23Dec2020. She had received mandatory COVID-19 testing on 23Dec2020, prior to being administered the vaccine; she received the negative results of that COVID-19 testing on 25Dec2020. After being administered the vaccine she was monitored for 15 minutes and then went home. She was fine, had no allergy or anything. She reported that after she was administered the vaccine, she had pain, was really tired, nauseous, chills, high temperature, and her eyes hurting. She mentioned history of COVID-19 in May2020. She works as nightshift nurse at a rehab facility. She woke up that night of 23Dec2020 around 9:00pm-10:30pm and had onset of pain in right arm at injection site which she did not take too seriously because when you get a shot you get pain. Around midnight that night 24Dec2020, she went to work and had onset of being really tired like she just wanted to sit or lay down; she felt like she had to sit down and could not stand well. She continued working that shift on 24Dec2020 but kept getting so tired and had onset of chills and was supporting herself with her med cart. She drank a little sip of ginger tea she brought to work think maybe that would help her feel better. She felt that if she drank more ginger tea she would throw up because she felt nauseous. She was really busy at work 24Dec2020 so she did not check her temperature until after 6:00am which was 103.8 degrees Fahrenheit; and thought no wonder she feels like throwing up. She finished her shift at like 7:00am. For 2 days her temperature was turning high temperature so every 6 hours she was taking Motrin 2-200mg and that would make her temperature go down. Then temperature would go back up to like 102.4 degrees Fahrenheit, she would take ibuprofen (MOTRIN) again, temperature would come down to like 101.3 degrees Fahrenheit. She continued feeling nauseated, having chills, headache and feeling nauseous which she felt all of which could be related to the temperature. She reported to her employee health at work. She thinks it's better. Saturday morning of 26Dec2020, she woke up with temperature of 100.6 degrees Fahrenheit at 7:00am which was the first time her temperature had gown down like that so she did not take the ibuprofen. She checked it again later at like 1:00 pm and temperature was 101.8 degrees Fahrenheit so she took 2 Motrin again. After that her temperature did not go up like that anymore, it was like 99.2 degrees Fahrenheit. As soon as she came from work on 24Dec2020 she called her doctor's office and was seen by Nurse Practitioner who let her out of work for like 2 days. She reported her eyes also have been hurting, mostly her right eye is still hurting, the top is hurting like when you have a small pimple so she keeps checking but does not see anything with her eye. She couldn't even put a cold compress on for the temperature because of her headache and her eyes hurting. She could not even put cold compress to bring her temperature down. Seriousness criteria of all events was unknown. The patient has had no rash, no breathing problems, no coughing, no sore throat or other serious events. She was scared because she wondered if she had COVID-19 again with these events. She mentioned if people do not know these are side effects they would be scared, but she knows from the information she got with the Pfizer BioNTech COVID-19 Vaccine that these are normal for everyone. The only thing she wondered about is if the tiredness she is having is serious or not. She reported prior to getting the COVID-19 vaccine she tested positive for COVID-19 in May2020 and was very sick at that time because she works in a health field with COVID-19 patients. Pfizer BioNTech COVID-19 Vaccine. The patient indicated that she was fine before she got the vaccine; she had no cold, no coughing, no sore throat. The ibuprofen tablet was administered as 200 mg, 2 of the tablets at a time. : The outcome of all the events was unknown. The relatedness of the event, pain to the suspect drug was reported as related from the reporter using the assessment; relatedness of the event, really tired to the suspect drug was reported as related from the reporter using the assessment; relatedness of the event, nauseous to the suspect drug was reported as related from the reporter using the assessment; relatedness of the event, chills to the suspect drug was reported as related from the reporter using the assessment; relatedness of the event, high temperature to the suspect drug was reported as related from the reporter using the assessment; relatedness of the event, eyes hurting to the suspect drug was reported as related from the reporter using the assessment. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 0920968
Sex: F
Age:
State: CT

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: It looks like one of the ingredients may have an animal cell lipid; Syncope; Dizziness; feeling faint; like going to pass out now and then; overall achiness, severe headaches, fever; overall achiness, severe headaches, fever; overall achiness, severe headaches, fever; This is a spontaneous report from a contactable nurse reporting for herself. This A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EH9899), intramuscular at single dose in the left arm on 22Dec2020 09:00 for covid-19 immunisation. Medical history included reaction to pork, porsine and/or if she ever was exposed to exposed to heparin. There were no concomitant medications. On 23Dec2020, the patient experienced syncope (medically significant), dizziness (medically significant), feeling faint; like going to pass out now and then (medically significant), overall achiness, severe headaches, fever. The outcome of the events syncope, dizziness, feeling faint; like going to pass out now was recovering and outcome of overall achiness, severe headaches, fever was recovered on 24Dec2020. The patient ask: are there any animal products, pork gelatin or a lipid form of that contain in the vaccine? The events were described as follows: She experienced a significant amount of syncope and dizziness, for greater than 4 or 5 days post-receiving the vaccination. Also feeling faint like she is going to pass out every now and then. Has a more important question, wondering along with the doctors if one of the ingredients may have an animal product, like pork gelatin or a lipid form of that. It looks like one of the ingredients may have an animal cell lipid and was wondering if she was having a reaction to that. Declines to provide primary care provider details. States she received this first dose at occupational health in her workplace. Received the vaccine on the 22Dec2020 at 9am. 24 hours post vaccination, 1 day after, the syncope, dizziness, feeling faint started. Also the other symptoms, overall achiness, severe headaches, and fever were also experienced, but they stopped after that 24 hours. Those were expected since it was listed as side effects that popped up, so she expected those and they stopped after 24 hours. The syncope, dizziness, and faint feeling are not any worse and are very slowly improving, but she still has it and had to call out of work today because of it. That's consistent. Mentions it takes her a while to get down the stairs when getting product details for the COVID-19 vaccine. Unable to provide the vaccine NDC or expiry, or dose. Did not have any other vaccines at time of this one and none 4 weeks prior. Had to call a (company withheld) doctor and has to go to occupational health tomorrow to be seen. Declines having COVID virus. No further details provided.; Sender's Comments: Based on the compatible time association, the events syncope and dizziness are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0920969
Sex: F
Age:
State: MA

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201221; Test Name: COVID-19 PCR test; Test Result: Negative

Allergies:

Symptoms: chest got tight; Shortness of breath; throat was itchy, and felt like it closed; throat was itchy, and felt like it closed; This is a spontaneous report from a contactable other health care professional (HCP) (also reported as respiratory therapist) from a Pfizer Sponsored Program. A 48-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK5730), via an unspecified route of administration on 21Dec2020 at 48-years-old at a single dose for COVID-19 immunization. Medical history included asthma from 2000 and ongoing (diagnosed 20 year ago). There were no concomitant medications. On 21Dec2020, the patient experienced: chest got tight (non-serious), shortness of breath (non-serious), throat was itchy, and felt like it closed. The clinical course was reported as follows: The caller was a respiratory therapist (also reported as health care professional (HCP)). The patient's first dose of the vaccine was on 21Dec2020 at the hospital where she works. Five hours after getting the vaccine, her chest got tight, she has shortness of breath, her throat was itchy, and she felt like it closed. The patient had asthma (diagnosed 20 years ago) and felt this reaction. It took 48 hours after the initial symptoms that she felt better. For treatment, the patient took her salbutamol (ALBUTEROL) inhaler and diphenhydramine hydrochloride (BENADRYL). The patient was scared to have the second dose; and she was going to talk to her primary care physician (PCP) about the second dose (but she did not think she would have much knowledge on what to do). The patient had a COVID PCR test the day she received the vaccine, and it was negative. The patient underwent lab tests and procedures which included COVID-19 PCR test: negative on 21Dec2020. The clinical outcome of the events was recovered on an unspecified date.

Other Meds:

Current Illness: Asthma (diagnosed 20 years ago)

ID: 0920970
Sex: M
Age:
State: VA

Vax Date: 12/17/2020
Onset Date: 12/19/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201220; Test Name: Fever; Result Unstructured Data: Test Result:100.4 Fahrenheit; Test Date: 20201220; Test Name: COVID-19 antigen test; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: positive COVID-19 antigen test with symptoms (ache, cough, fever); positive COVID-19 antigen test with symptoms (ache, cough, fever); This is a spontaneous report from a contactable physician (patient). A 51-year-old male patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration on 17Dec2020 at 10:30 at single dose in left arm for covid-19 immunization. Medical history included borderline diabetes, ongoing hypertension, ongoing hyperlipidemia, ongoing rhinitis allergic, and currently ill. Concomitant medication included ongoing fexofenadine hydrochloride (ALLEGRA, strength: 180 mg) at 180mg once daily by mouth for Rhinitis allergic taking for years, ongoing lisinopril (strength: 40 mg) at 40 mg once daily by mouth for hypertension taking for two or three years, ongoing atorvastatin (strength: 40 mg) at 40 mg once daily by mouth for hyperlipidemia taking for a year. The patient experienced positive covid-19 antigen test with symptoms (ache, cough, fever) from 19Dec2020. Event details: The patient received the COVID 19 Vaccine on 17Dec2020 10:30AM in the left arm. Tested for COVID 19 with the antigen test, on 20Dec2020 and his result was positive, he experienced ache and cough on 19Dec2020. Clarified he started having symptoms in the evening (19Dec2020) and then tested in the morning (20Dec2020). He experienced the low grade fever on 20Dec2020. His maximum temperature was 100.4 fahrenheit. He had only been treated with over the counter products. No further information provided for the over the counter products. He was not hospitalized. He will take the second dose of the COVID 19 vaccine on 07Jan2021. The patient didn't have SARS-CoV2 antibodies at diagnosis. The patient was not admitted to an Intensive Care Unit. The patient didn't display clinical signs at rest indicative of severe systemic illness. The patient didn't require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. The patient didn't have any pre-existing diseases worsened during the SARS-CoV2 infection. The patient was not treated with immunomodulating or immunosuppressing medications or received any other vaccines around the time of COVID-19 vaccination. The outcome of all his symptoms was resolving.; Sender's Comments: The reported events drug ineffective and COVID-19 are likely intercurrent and are unrelated to suspect drug BNT162B2 based on short temporal relation between vaccination and onset of events.

Other Meds: ALLEGRA; ;

Current Illness: Hyperlipidemia; Hypertension; Rhinitis allergic

ID: 0920971
Sex: F
Age:
State: FL

Vax Date: 12/21/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:120/80; Test Name: bone density; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: sweats; Feeling of unwellness like she had the virus or bad flu; Feeling of unwellness like she had the virus or bad flu; could not hardly open eyes/eyes were very heavy; could not hardly open eyes/eyes were very heavy; chills; tiredness; headache; muscle pain; weakness; Joint pain; Fever; Injection site swelling and redness; Injection site swelling and redness; injection site pain; Nausea; This is a spontaneous report from a contactable consumer. A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left upper arm, on 21Dec2020 (at the age of 70-years-old) at a single dose for COVID-19 immunization. Medical history included COVID-19 (lasted 3 weeks), high blood pressure (family history in mother and father), lumpectomy, breast cancer, radiation treatment, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities, diabetes, obesity, fibroid tumors, fibroid tumors surgery, thyroid problem, bone density problem, and lower lobe left of lung piece cut out (not cancer). The patient previously received chemotherapy (MANUFACTURER UNKNOWN) for breast cancer, pethidine hydrochloride (DEMEROL) for post fibroid tumors surgery and experienced swollen hands and arms, influenza vaccine (MANUFACTURER UNKNOWN) in 2020 (usually gets swelling/red arm), and oxycodone hydrochloride;paracetamol (PERCOCET) and experienced feeling sick. Concomitant medications included unspecified medications for high blood pressure, thyroid problem, and bone density problem and unspecified nasal spray, water pill, and vitamins. The patient experienced could not hardly open eyes/eyes were very heavy, chills, tiredness, headache, muscle pain, weakness, joint pain, fever, injection site swelling and redness, injection site pain, nausea, sweats, and feeling of unwellness like she had the virus or bad flu on 22Dec2020. The clinical course was reported as follows: The patient felt fine the day when injection was given, but the next day, it was like she had COVID again. She had COVID 3 months ago and it lasted for 3 weeks. It was the same symptoms she had. She could not open her eyes hardly. They were very heavy. The patient had the chills, temperature, sweats, and injection site pain (the next day). There was also swelling and redness that remained for 6 days. The patient reported that if she still puts her hand on it now, there is some sensitivity. She also had tiredness and headache. The patient reported that she only had each of these symptoms for 24 hours (as reported) and the headache was gradually improved. The patient had muscle pain and weakness. She laid down and all she could do was sleep for 24 hours. The patient had nausea for 4 days. She did not have swollen lymph nodes. The patient underwent lab tests and procedures which included blood pressure: 120/80 on an unspecified date and bone density: unknown results on an unspecified date. The clinical outcome of could not hardly open eyes/eyes were very heavy, chills, tiredness, headache, muscle pain, weakness, joint pain, fever, sweats, and feeling of unwellness like she had the virus or bad flu was recovered on an unspecified date, nausea was recovered on 26Dec2020, and injection site swelling and redness and injection site pain was recovered on 28Dec2020. The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm